Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PPAR-γ Modulators as Current and Potential Cancer Treatments
Tiange Chi, Mina Wang, Xu Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

The role of lipids in cancer progression and metastasis
Miguel Martín‐Pérez, Uxue Urdiroz-Urricelqui, Claudia Bigas, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1675-1699
Open Access | Times Cited: 258
mRNA vaccine in cancer therapy: Current advance and future outlook
Youhuai Li, Mina Wang, Xueqiang Peng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 74
The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access | Times Cited: 2
Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6099-6099
Open Access | Times Cited: 13
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges
Jiyun Zhang, Miru Tang, Jinsai Shang
Biomolecules (2024) Vol. 14, Iss. 2, pp. 190-190
Open Access | Times Cited: 10
Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective
Manamele D. Mashabela, Abidemi Paul Kappo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5659-5659
Open Access | Times Cited: 9
Regulatory role of PPAR in colorectal cancer
Cong Wang, Tingcong Lv, Binghui Jin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer
Sangeeta Ballav, Bini Biswas, Vishal Kumar Sahu, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3215-3215
Open Access | Times Cited: 29
The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy
Jiaao Sun, Liyan Yu, Xueling Qu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 18
Loratidine is associated with improved prognosis and exerts antineoplastic effects via apoptotic and pyroptotic crosstalk in lung cancer
Xiwen Liu, Ran Zhong, Jiaxing Huang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Modular Hub Genes in DNA Microarray Suggest Potential Signaling Pathway Interconnectivity in Various Glioma Grades
Marco A. Orda, Peter Matthew Paul Fowler, Lemmuel L. Tayo
Biology (2024) Vol. 13, Iss. 4, pp. 206-206
Open Access | Times Cited: 6
Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
Prerna R. Nepali, Natasha Kyprianou
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Analogues of Anticancer Natural Products: Chiral Aspects
Jindra Valentová, Lucia Lintnerová, Natalia Miklášová, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5679-5679
Open Access | Times Cited: 14
Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
Chaobiao Yan, Li Yu, Hanqing Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188905-188905
Closed Access | Times Cited: 13
Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer
Victória Bombarda-Rocha, Dany Silva, Allal Badr-Eddine, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 4013-4013
Open Access | Times Cited: 11
Pioglitazone enhances cisplatin’s impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
Qamraa H. Alqahtani, Layla A. Al‐Kharashi, Hanaa N. Alajami, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102059-102059
Open Access | Times Cited: 4
Synthesis and in vitro cytotoxicity of benzoxazole‐based PPARα/γ antagonists in colorectal cancer cell lines
Nazaret Moreno‐Rodríguez, Antonio Laghezza, Carmen Cerchia, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Open Access | Times Cited: 4
Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas
Jerry Xiao, Reetu Mukherji, George Sidarous, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 355-355
Open Access
The role of perfluorooctane sulfonic acid (PFOS) exposure in inflammation of intestinal tissues and intestinal carcinogenesis
Jerika Durham, Josiane Weber Tessmann, Pan Deng, et al.
Frontiers in Toxicology (2023) Vol. 5
Open Access | Times Cited: 10
Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment
Maria Vasileiou, Sotirios Charalampos Diamantoudis, Christina Tsianava, et al.
Applied Sciences (2025) Vol. 15, Iss. 4, pp. 1925-1925
Open Access
From Apo to Ligand-Bound: Unraveling PPARγ-LBD Conformational Shifts via Advanced Molecular Dynamics
Emanuele Falbo, Pietro Delre, Antonio Lavecchia
ACS Omega (2025)
Open Access
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications
В. В. Соболев, Ekaterina Tchepourina, А. Г. Соболева, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 534-534
Open Access
PPARγ: A Key to Personalized Treatment
Sunaina Gautam, S B Kumari, Deepak Chandra Misra, et al.
Aspects of Molecular Medicine (2025), pp. 100081-100081
Open Access
Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases
Alpana Singh, Rishabh Chaudhary
International Immunopharmacology (2025) Vol. 155, pp. 114616-114616
Closed Access
Page 1 - Next Page

Scroll to top